Sort   by:  
 Page size 
UnknownGDF11 Implications in Cancer Biology and Metabolism. Facts and Controversies.
Not available
S-EPMC6803553 | biostudies-literature
UnknownIsatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study.
Not available
S-EPMC12572944 | biostudies-literature
UnknownElectrodiagnostic subtyping in Guillain-Barre syndrome patients in the International Guillain-Barre Outcome Study.
Not available
S-EPMC11295174 | biostudies-literature
UnknownBiallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy.
Not available
S-EPMC8557332 | biostudies-literature
UnknownHigh mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
Not available
S-EPMC7789078 | biostudies-literature
UnknownAmong classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.
Not available
S-EPMC7871138 | biostudies-literature
UnknownLong-term follow-up of recovered MPN patients with COVID-19.
Not available
S-EPMC8208062 | biostudies-literature
UnknownSecond versus first wave of COVID-19 in patients with MPN.
Not available
S-EPMC8776551 | biostudies-literature
UnknownDetailed stratified GWAS analysis for severe COVID-19 in four European populations.
Not available
S-EPMC9703941 | biostudies-literature
UnknownDeterminants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Not available
S-EPMC9538387 | biostudies-literature
Sort   by:  
 Page size